Overview

Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of allogeneic adipose-derived stem cells (ALLO-ASC) in patients with lateral epicondylitis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Anterogen Co., Ltd.